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ABSTRACT 
 
 This is a prospective hospital-based study on the clinical patterns of 
major LEAs in diabetic patients in KTH and Gabir Abu El Izz center 
during the period July 2002 to January 2003. 
 Objectives:  The aim was to identify the anatomical levels and 
indications of major LEAs in diabetic patients undergoing major LEAs in 
KTH  and  Gabir Abu  El Izz center during the period July 2002 to January 
2003. The study also explored the rates of primary healing, post operative 
complications, reoperation, morbidity and mortality at the various levels of 
major LEA. 
 Methods: Consecutive seventy diabetic patients underwent major 
LEA during the study period, were included. A data sheet was completed by 
interviewing, examining, investigating and following up all patients. 
 Results: Seventy patients were included in this study. Their age 
ranged between 35-92 years with a mean age of 61.5 years ± SD 11.85.The 
male to female ratio was 1.5:1. Ninety-six percent had NIDDM while (4%) 
had IDDM. The mean duration of diabetes was 18.3years ± SD 9.04. Sixteen 
percent were hypertensive and nineteen percent were regular smokers. 
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Eighty-six percent of our patient did not have previous foot education. 
Thirty patients (42.85%) had history of previous foot ulceration and thirty-
one had history of previous minor or major LEA. 
 Fifty-two patients   (74.28%)  had  transtibial   amputation   and   18   
had transfemoral amputation. No Symes, through knee or hip disarticulation 
were encountered. The ratio of transtibial to transfemoral amputation was 
(2.9 :1). 
 The indication of major LEA was control of sepsis in 27 (37.14%) 
patients, gangrene of the foot in thirteen patients and extensive tissue loss in 
(18.55%), followed by various combination of sepsis, gangrene and 
extensive tissue loss in the remaining patients. 
 Forty-seven LEAs (67.00%) were done under spinal anesthesia, 19 
(27.00%) were done under general anesthesia and only 4 (6.00%) were done 
under local anesthesia. 
 The wound was closed primarily in sixty-one patients (87.14%) and 
was left open in 9 patients (12.86%). The wound was closed without a drain 
in fifty-six patients (80.00%) and with a drain in 5 patients (7.14%). 
 Compared to transtibial amputation transfemoral amputations were 
associated with statistically significant: lower primary healing rate, higher 
postoperative complications rate, higher reoperation rate, and higher 
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mortality rate. The rate of in-hospital mortality was (20%). The mean 
duration of hospital stay was 30.14 days±21.87 with no significant 
difference in the hospital stay in relation to the level of the amputation. 
 Conclusion: Transtibial and transfemoral amputations are the main 
types of major LEA in diabetic patients in KTH and Gaber Abu El Izz 
diabetes center. The most common indication of major LEA is control of 
sepsis followed by gangrene of the foot and various combinations of sepsis, 
gangrene and extensive tissue loss. Transfemoral amputations are associated 
with higher rates of complications, reoperation, delayed healing and 
mortality. 
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  ﻤﻠﺨﺹ ﺍﻷﻁﺭﻭﺤﺔ
 
ﺃﺠﺭﻯ ﻫﺫﺍ ﺍﻟﺒﺤﺙ ﻟﺩﺭﺍﺴﺔ ﺍﻟﻨﻤﺎﺫﺝ ﺍﻟﺴﺭﻴﺭﻴﺔ ﻟﻌﻤﻠﻴﺔ ﺒﺘﺭ ﺍﻷﻁﺭﺍﻑ ﺍﻟﺴﻔﻠﻰ ﻟﻠﻤﺼﺎﺒﻴﻥ   
ﻱ ﺒﻤﺴﺘﺸﻔﻰ ﺍﻟﺨﺭﻁﻭﻡ ﺍﻟﺘﻌﻠﻴﻤﻲ ﻭﻤﺭﻜﺯ ﺠﺎﺒﺭ ﺃﺒﻭ ﺍﻟﻌﺯ ﺍﻟﺘﺨﺼﺼﻲ ﻟﻌﻼﺝ ﺭﺒﻤﺭﺽ ﺍﻟﺴﻜ
  . ﻡ3002ﻡ ﺤﺘﻰ ﻴﻨﺎﻴﺭ 2002ﺍﻟﺴﻜﺭﻱ ﺒﻤﺩﻴﻨﺔ ﺍﻟﺨﺭﻁﻭﻡ ﻭﺫﻟﻙ ﻓﻲ ﺍﻟﻔﺘﺭﺓ ﻤﻥ ﻴﻭﻟﻴﻭ 
  : ﺃﻫﺩﺍﻑ ﺍﻟﺩﺭﺍﺴﺔ
ﺍﻟﻬﺩﻑ ﻤﻥ ﺍﻟﺩﺭﺍﺴﺔ ﺍﻟﺘﻌﺭﻑ ﻋﻠﻰ ﺍﻟﻤﺴﺘﻭﻴﺎﺕ ﺍﻟﺘﺸﺭﻴﺤﻴﺔ ﻭﺍﻟﺩﻭﺍﻋﻲ ﺍﻟﺠﺭﺍﺤﻴﺔ ﻟﻘﺩ ﻜﺎﻥ   
ﻟﻌﻤﻠﻴﺎﺕ ﺒﺘﺭ ﺍﻷﻁﺭﺍﻑ ﺍﻟﺴﻔﻠﻰ ﻟﺩﻯ ﻤﺭﻀﻰ ﺍﻟﺴﻜﺭﻱ ﻓﻲ ﺍﻟﻤﺴﺘﺸﻔﻰ ﻭﺍﻟﻤﺭﻜﺯ ﺍﻟﻤﺫﻜﻭﺭﻴﻥ 
ﺃﻋﻼﻩ ﺨﻼل ﺍﻟﻔﺘﺭﺓ ﺍﻟﻤﺫﻜﻭﺭﺓ ﻭﻗﺩ ﺘﻨﺎﻭﻟﺕ ﺍﻟﺩﺭﺍﺴﺔ ﺒﺎﻟﺒﺤﺙ ﺃﻴﻀﺎﹰ ﻤﻌﺩﻻﺕ ﺍﻹﻟﺘﺌﺎﻡ ﺍﻷﻭﻟﻲ، 
ﺍﺤﺔ ﻭﻨﺴﺒﺔ ﺍﻟﻭﻓﻴﺎﺕ ﻭﻤﺘﻭﺴﻁ ﻤﻌﺩل ﺍﻟﻤﻜﻭﺙ ﻓﻲ ﻤﻀﺎﻋﻔﺎﺕ ﻤﺎ ﺒﻌﺩ ﺍﻟﺠﺭﺍﺤﺔ، ﺇﻋﺎﺩﺓ ﺍﻟﺠﺭ
  . ﺍﻟﻤﺴﺘﺸﻔﻰ ﻟﻠﻤﺴﺘﻭﻴﺎﺕ ﺍﻟﺘﺸﺭﻴﺤﻴﺔ ﺍﻟﻤﺨﺘﻠﻔﺔ
  :  ﺍﻟﻤﻨﻬﺞ
ﺍﻟﺩﺭﺍﺴﺔ ﺴﺒﻌﻴﻥ ﻤﺭﻴﻀﺎﹰ ﺃﺠﺭﻴﺕ ﻟﻬﻡ ﻋﻤﻠﻴﺎﺕ ﺒﺘﺭ ﻜﺒﻴﺭﺓ ﻟﻸﻁﺭﺍﻑ ﺍﻟﺴﻔﻠﻰ  ﺘﻨﺎﻭﻟﺕ   
ﺘﺒﺎﻋﺎﹰ ﺨﻼل ﻓﺘﺭﺓ ﺍﻟﺩﺭﺍﺴﺔ ﻭﻗﺩ ﺘﻡ ﺠﻤﻊ ﺍﻟﺒﻴﺎﻨﺎﺕ ﻤﻥ ﺨﻼل ﺇﺠﺭﺍﺀ ﺍﻟﻤﻘﺎﺒﻼﺕ ﻟﻠﻤﺭﻀﻰ ﻭﺇﺠﺭﺍﺀ 
  . ﻲ ﻭﺍﻟﻔﺤﻭﺼﺎﺕ ﻟﻬﻡ ﻭﻤﺘﺎﺒﻌﺘﻬﻡﺍﻟﻜﺸﻑ ﺍﻟﻁﺒﻴ
  : ﺍﻟﻨﺘﺎﺌﺞ
  ﺘﻨﺎﻭﻟﺕ ﺍﻟﺩﺭﺍﺴﺔ ﺒﺎﻟﺒﺤﺙ ﺴﺒﻌﻴﻥ ﻤﺭﻴﻀﺎﹰ ﺒﺎﻟﺴﻜﺭﻱ ﺘﺭﺍﻭﺤﺕ ﺃﻋﻤﺎﺭﻫﻡ ﺒﻴﻥ   
ﻭﻜﺎﻨﺕ ( 58.11±)ﻭﺇﻨﺤﺭﺍﻑ ﻤﻌﻴﺎﺭﻱ ( 5.16)ﺴﻨﺔ ﻓﻲ ﻤﺘﻭﺴﻁ ﻋﻤﺭﻱ ﺒﻠﻎ ( 29 – 53)
ﻤﻥ ﺍﻟﻤﺭﻀﻰ ﻏﻴﺭ ﻤﻌﺘﻤﺩﻴﻥ ﻋﻠﻰ ﻋﻘﺎﺭ % 69 ﻭﻗﺩ ﻜﺎﻥ 10 – 5.1ﻨﺴﺒﺔ ﺍﻟﺫﻜﻭﺭ ﺇﻟﻰ ﺍﻹﻨﺎﺙ 
  . ﻤﻨﻬﻡ ﻤﻌﺘﻤﺩﻴﻥ ﻋﻠﻴﻪ% 4  ﻥﺍﻹﻨﺴﻭﻟﻴ
ﻤﻥ % 61، ( 45.9±) ﺴﻨﺔ ﺒﺈﻨﺤﺭﺍﻑ ﻤﻌﻴﺎﺭﻱ 3.81ﺒﻠﻎ ﻤﺘﻭﺴﻁ ﻓﺘﺭﺓ ﺍﻟﻤﺭﺽ 
ﺘﺜﻘﻴﻔﺎﹰ  ﻤﻨﻬﻡ ﻟﻡ ﻴﺘﻠﻘﻭﺍ% 68ﻴﺩﺨﻨﻭﻥ ﺒﺎﻨﺘﻅﺎﻡ % 91ﺍﻟﻤﺭﻀﻰ ﻴﻌﺎﻨﻭﻥ ﻤﻥ ﺍﺭﺘﻔﺎﻉ ﻀﻐﻁ ﺍﻟﺩﻡ ﻭ 
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 13ﻤﻨﻬﻡ ﻜﺎﻨﻭﺍ ﻗﺩ ﺘﻌﺭﻀﻭﺍ ﻟﺘﻘﺭﺤﺎﺕ ﻓﻲ ﺍﻟﻘﺩﻡ ﻭ %( 8.24 )03ﺼﺤﻴﺎﹰ ﺒﺨﺼﻭﺹ ﺍﻟﻘﺩﻡ ﻭ 
  . ﺕ ﻟﻬﻡ ﻋﻤﻠﻴﺎﺕ ﺒﺘﺭ ﻜﺒﻴﺭﺓ ﺃﻭ ﺼﻐﻴﺭﺓ ﻟﻸﻁﺭﺍﻑ ﺍﻟﺴﻔﻠﻰﻤﻨﻬﻡ ﺃﺠﺭﻴ%( 34)
ﻤﻥ ﺍﻟﻤﺭﻀﻰ ﺃﺠﺭﻴﺕ ﻟﻬﻡ ﻋﻤﻠﻴﺎﺕ ﺒﺘﺭ ﺘﺤﺕ ﻤﺴﺘﻭﻯ ﻤﻔﺼل ﺍﻟﺭﻜﺒﺔ %( 82.47 )25
  . ﺃﺠﺭﻱ ﻟﻬﻡ ﺒﺘﺭ ﻓﻭﻕ ﻤﺴﺘﻭﻯ ﻤﻔﺼل ﺍﻟﺭﻜﺒﺔ( 27.52 )81ﻭ 
  1 : 9.2 ﻨﺴﺒﺔ ﺍﻟﺒﺘﺭ ﺍﻟﻤﺫﻜﻭﺭ ﺃﻭﻻﹰ ﺇﻟﻰ ﺍﻟﻤﺫﻜﻭﺭ ﺜﺎﻨﻴﺎﹰ ﻜﺎﻨﺕ   
ﻤﺭﻴﻀﺎﹰ، %( 41.73 )72ﺤﻜﻡ ﻓﻲ ﺨﻤﺞ ﺒﺎﻟﻘﺩﻡ ﻓﻲ ﺍﻟﺩﻭﺍﻋﻲ ﺍﻟﺠﺭﺍﺤﻴﺔ ﻟﻠﺒﺘﺭ ﻜﺎﻨﺕ ﺍﻟﺘ  
% 55.81 ﻤﺭﻴﻀﺎﹰ ، ﻭﻓﻘﺩﺍﻥ ﺃﺠﺯﺍﺀ ﻜﺒﻴﺭﺓ ﻭﻤﻬﻤﺔ ﻓﻲ ﺍﻟﻘﺩﻡ 31ﺕ ﻭﻏﺭﻏﺭﻨﻴﺔ ﺒﺎﻟﻘﺩﻡ ﻓﻲ ﺘﻤﻭ
ﻤﻥ ﺍﻟﻤﺭﻀﻰ ﺒﺎﻹﻀﺎﻓﺔ ﺇﻟﻰ ﺘﺠﻤﻌﺎﺕ ﻤﺨﺘﻠﻔﺔ ﻤﻥ ﺍﻟﺨﻤﺞ ﻭﺍﻟﻐﺭﻏﺭﻴﻨﺔ ﻭﻓﻘﺩﺍﻥ ﻤﻌﻅﻡ ﺃﻨﺴﺠﺔ 
 . ﺍﻟﻘﺩﻡ ﻓﻲ ﺒﻘﻴﺔ ﺍﻟﻤﺭﻀﻰ
ﻋﻤﻠﻴﺔ ﺃﺠﺭﻴﺕ %( 0.72 )91 ﻭ ﻋﻤﻠﻴﺔ ﺃﺠﺭﻴﺕ ﺘﺤﺕ ﺍﻟﺒﻨﺞ ﺍﻟﻨﺼﻔﻲ%( 0.76)74  
  . ﻋﻤﻠﻴﺎﺕ ﺃﺠﺭﻴﺕ ﺒﺒﻨﺞ ﻤﻭﻀﻌﻲ%( 0.6 )4ﺘﺤﺕ ﺍﻟﺒﻨﺞ ﺍﻟﻌﻤﻭﻤﻲ ﻤﻥ ﻭ 
ﻤﺭﻴﻀﺎﹰ ﻭﺘﺭﻙ ﺍﻟﺠﺭﺡ ﻤﻔﺘﻭﺤﺎﹰ ﻓﻲ %( 41.78 )16ﺘﻡ ﻗﻔل ﺍﻟﺠﺭﺍﺡ ﺒﺼﻭﺭﺓ ﺃﻭﻟﻴﺔ ﻓﻲ   
 5 ﻤﺭﻴﻀﺎﹰ ﻭﺒﻭﺠﻭﺩ ﺩﺭﻴﻥ ﻓﻲ 65ﺘﻡ ﻗﻔل ﺍﻟﺠﺭﺡ ﺒﺩﻭﻥ ﺩﺭﻴﻥ ﻓﻲ %( 68.21) ﻤﺭﻀﻰ 9
  . ﻤﺭﻀﻰ
ﺒﺎﻟﺒﺘﺭ ﺘﺤﺕ ﺍﻟﺭﻜﺒﺔ ﻭﺠﺩﻨﺎ ﺍﻟﺒﺘﺭ ﺍﻻﻭل ﻭﺒﺼﻭﺭﺓ ﺇﺤﺼﺎﺌﻴﺔ ﺒﻤﻘﺎﺭﻨﺔ ﺍﻟﺒﺘﺭ ﻓﻭﻕ ﺍﻟﺭﻜﺒﺔ 
ل ﺃﻜﺒﺭ ﻤﻬﻤﺔ ﻤﺼﺤﻭﺒﺎﹰ ﺒﻤﻌﺩﻻﺕ ﺍﻟﺘﺌﺎﻡ ﺃﻭﻟﻲ ﺃﻗل، ﻭﺒﻤﻌﺩل ﻤﻀﺎﻋﻔﺎﺕ ﺃﻜﺒﺭ ﺒﻌﺩ ﺍﻟﺠﺭﺍﺤﺔ ﻭﻤﻌﺩ
ﻭﺒﻠﻎ ﻤﻌﺩل % 17.51ﻹﻋﺎﺩﺓ ﺍﻟﺠﺭﺍﺤﺔ ﻭﻤﻌﺩل ﺃﻜﺒﺭ ﻟﻠﻭﻓﺎﺓ ﺒﻠﻎ ﻤﻌﺩل ﺍﻟﺨﻤﺞ ﺒﻌﺩ ﺍﻟﺠﺭﺍﺤﺔ 
 ﻴﻭﻤﺎﹰ ﺒﺈﻨﺤﺭﺍﻑ ﻤﻌﻴﺎﺭﻱ 41.03ﺸﻔﻰ ﻭﺒﻠﻎ ﻤﺘﻭﺴﻁ ﺍﻟﻤﻜﻭﺙ ﻓﻲ ﺍﻟﻤﺴﺘ% 02ﺍﻟﻭﻓﺎﺓ ﺒﺎﻟﻤﺴﺘﺸﻔﻰ 
ﻟﻡ ﻨﺠﺩ ﺍﺨﺘﻼﻑ ﺇﺤﺼﺎﺌﻲ ﻤﻬﻡ ﻓﻲ ﻓﺘﺭﺓ ﺍﻟﻤﻜﻭﺙ ﻓﻲ ﺍﻟﻤﺴﺘﺸﻔﻰ ﺒﺎﻟﻨﺴﺒﺔ ﻟﻠﺒﺘﺭ ﻓﻭﻕ . 78.1 ±
  . ﺍﻟﺭﻜﺒﺔ ﻤﻘﺎﺭﻨﺔ ﺒﺎﻟﺒﺘﺭ ﺘﺤﺕ ﺍﻟﺭﻜﺒﺔ
  : ﺍﻟﺨﻼﺼﺔ
ﺍﻟﺒﺘﺭ ﻓﻭﻕ ﺍﻟﺭﻜﺒﺔ ﻭﺘﺤﺕ ﺍﻟﺭﻜﺒﺔ ﻫﻲ ﺍﻷﻨﻤﺎﻁ ﺍﻟﺴﺭﻴﺭﻴﺔ ﻟﻠﺒﺘﺭ ﺍﻟﻜﺒﻴﺭ ﻓﻲ ﺍﻷﻁﺭﺍﻑ 
ﺍﻟﺨﺭﻁﻭﻡ ﻭﻤﺭﻜﺯ ﺠﺎﺒﺭ ﺃﺒﻭ ﺍﻟﻌﺯ ﺍﻟﺘﺨﺼﺼﻲ ﻟﻌﻼﺝ ﺍﻟﺴﻔﻠﻰ ﻟﻤﺭﻀﻰ ﺍﻟﺴﻜﺭﻱ ﻓﻲ ﻤﺴﺘﺸﻔﻰ 
  . ﻤﺭﺽ ﺍﻟﺴﻜﺭﻱ
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ﻡﺩﻘﻟﺍ ﺕﻭﻤﺘﻭ ﺞﻤﺨﻟﺍ ﻲﻓ ﻡﻜﺤﺘﻟﺍ ﻲﻫ ﻰﻠﻔﺴﻟﺍ ﻑﺍﺭﻁﻷﺍ ﺭﺘﺒﻟ ﺔﻴﺤﺍﺭﺠﻟﺍ ﻲﻋﺍﻭﺩﻟﺍ ﻡﻫﺃ .
 ﺔﺤﺍﺭﺠﻟﺍ ﺭﺍﺭﻜﺘﻭ ﺡﺍﺭﺠﻟﺍ ﺩﻌﺒ ﺎﻤ ﺕﺎﻔﻋﺎﻀﻤﻟ ﺭﺒﻜﺃ ﺕﻻﺩﻌﻤﺒ ﺏﻭﺤﺼﻤ ﺔﺒﻜﺭﻟﺍ ﻕﻭﻓ ﺭﺘﺒﻟﺍ
ﺓﺎﻓﻭﻟﺍﻭ ﻡﺎﺌﺘﻟﻹﺍ ﺭﺨﺄﺘﻭ .  
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Introduction & Literature Review 
1 
 
1 
 
 
1.1 INTRODCTION 
 
 Diabetes mellitus is a common condition. It is a serious, chronic 
disease caused by both hereditary and environmental factors. The 1996 
global diabetes prevalence of 120 million is predicted to more than double to 
250 million by the year 2005, due to the increasing age, obesity, sedentary 
lifestyles, changing dietary patterns and adoption of more strict criteria for 
diagnosis (1). Using strict diagnostic criteria (blood glucose more than ten 
mmol/L at two hour following a standard glucose tolerance test) between l 
and 2 percent of the population is affected (2). According to their absolute 
requirement for insulin in order to remain ketosis free, diabetic patients may 
be classified into two groups, insulin dependant (IDDM) and insulin non 
dependant (NIDDM). Insulin dependant diabetics represent one-fifth of 
diabetic patient's (3). 
 Following the introduction of insulin and more recently the oral 
hypoglycemic agents, the control of diabetes has markedly improved, and 
the major problem facing diabetic patients, is the development of the long 
term complications of the disease, such as neuropathy, angiopathy and 
ocular complications. 
 A further cause of illness and disability in diabetes is the development 
of foot complications. Diabetes -related foot problems result in significant 
social, medical and economic consequences, and constitute the most 
frequent reason for hospitalization in patients with diabetes, accounting for 
up to 25 percent of all diabetes related admissions in the United States and 
Great Britain (4, 5). 
2 
 
 Accurate population-based statistics concerning the current incidence 
and prevalence of foot ulcers in developed countries is not available. Most of 
the available data are based on cross-sectional studies of selected patient 
populations of diabetic subjects. The point prevalence of foot ulcer in 
developed countries has been estimated to be approximately 4-10% of 
diabetic individuals (1). A corresponding incidence of 2.2-5.9 % has also 
been reported (1). 
 Lower limb amputation is one of the most feared complications of 
diabetes. It is associated with a high mortality rate and considerable loss of 
the walking ability and independence among survivors. If an amputation has 
been performed, the risk of further ulceration is greatly increased, there is 
also an increased risk that the other limb will also require amputation and the 
patient 5year survival will be reduced. 
 The United States National Commission on Diabetes estimates that 
(5%) (16 million) of the United State population are diabetics, (15%) of 
diabetic United State population will develop a foot ulcer at some time in 
their life. About 1 in 150 diabetic patients per year will require an 
amputation of some sort. These Figures agree well with the Oxford Diabetes 
Study where amputation rate was 8 per 1000 person years. Data from the 
United States National Hospital Discharge Survey found an annual average 
of 110,000 amputations for the period 1989-1992 .Of all the discharge listing 
lower limb amputation, about (51%) are also listed diabetic (6). 
 Patients who have undergone a major lower limb amputation have a 
high risk of a subsequent ipsilateral or contralateral amputation .It has been 
estimated that (9 %) to (20 %) of diabetic individual experience a second 
amputation during a separate hospitalization (7). The postoperative mortality 
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is significantly higher in transfemoral amputation (10-40 %) than in 
transtibial amputation (5-20 %), probably because more fragile patients are 
selected for primary transfemoral amputation .The 5-year risk of a second 
leg amputation after an initial amputation is (28-51%) (1). The 5-year 
mortality rates after LEA among the diabetic population is (68 %) (1). 
In the United Kingdom, around (2%) of the whole population are affected by 
diabetes. The Oxford Community Diabetes Study found a 7 % prevalence of 
active foot ulceration and a (3 %) prevalence of amputation of all or part of a 
foot(8). Problems associated with the diabetic foot account for (50 %) of bed 
use due to diabetes in UK (9). Further, median survival post-amputation is 
less than 2 years (10). 
 There is a lower incidence rate of lower extremity amputation in 
patient with diabetes mellitus of Asian ethnic origin (3-4 cases per 10,000 
per year) compared to 14.2 cases per 10,000 in white Caucasians (11). This is 
mostly explained by low rates of PVD and neuropathy in south Asian and in 
part associated with low rates of smoking (12). 
 A recent audit of lower limb amputees in Scotland carried out by the 
Scottish Physiotherapy Amputee Research Group (SPARG) found that 
(30%) of cases undergoing LEA involved patients known to be diabetics (13). 
However, previous studies in Scotland suggested that these Figures might be 
low (14). Therefore, SPARG, in collaboration with the Scottish Vascular 
Audit Group (SVAG), conducted a 3-month (1/5/1995-31/7/1995) 
prospective study of the diagnosis of diabetes in patients presenting for 
lower limb amputation at vascular units throughout Scotland. This study 
suggested that significant proportion of patient currently presenting for 
(LEA) in Scotland have undiagnosed diabetes. The study concluded that the 
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true incidence of diabetes among amputees in Scotland is likely to be over 
(50 %). In this study all patients who were not known diabetic and 
presenting for a (LEA) had a fasting plasma glucose (FPS) test. Values 
above 6.6mmol/L (118.8mg\d) were considered diagnostic of diabetes. The 
positive predictive value (PV+) for a threshold of 6.6mmol/L is (45-55 %) in 
the general population .The (PV+), however is increased by the presence of 
one or more risk factors for diabetes, these risk factors include age over 50 
years, obesity and physical inactivity (15). Patient presenting for amputation 
in Scotland are over 60, and many are likely to have other risk factors as 
well, thus significantly increasing the (PV+) in that study population. 
In Poland a cross sectional study of the incidence of any non-
traumatic and non-neoplastic (LEAs) in the population Krakow region 
(1,293,703) between (1/1/1996-31/12/1996) was done. A total of 290 non-
traumatic and non-neoplastic (LEAs) were identified. (47.9%) of the (LEAs) 
were performed in diabetic's .An incidence rate of (LEAs) of 186.7 per 
100,000 per year in diabetics were calculated (16). 
 In Germany, a study on the incidence of non-traumatic (LEAs) in 
residents of Leverkusen  during the period (1994-1998) revealed an 
incidence rate of amputation in diabetic population of 463 per 1000,000 
person-year (17). 
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1.2 LITERATURE REVIEW 
 
Evolution of amputation surgery: 
The earliest anthropological evidence of an amputee is that of a 
human skull in the Smithsonian institution 45,000 year old that shows the 
teeth shaped and aligned in such away that indicate he was an upper 
extremity amputee (18). Other evidence is found in cave printing in Spain and 
France, about 36,000 years old, which show the negative imprints of a 
mutilated hand. Late painting, like these were also found in New Mexico(19). 
Early surgical amputation was a crude procedure by which a limb was 
rapidly severed from unanaesthetized patient; for haemostasis the open 
stump was crushed or was dipped in boiling oil (20). Surgery was performed 
without anesthesia, analgesia and fairly advanced tools. For judicial 
punishment no anesthesia was used and a guillotine technique with an ax 
was used. .Analgesic plants such as asperic acid from Tree Park were used to 
relieve pain (21). Ligature of cotton fiber, human hair, or ant jaws may also 
have been used in weaving cultures. Tools such as bronze or stone axes were 
the standard surgical instrument (19). 
The reason for amputation in ancient times varied. Congenital 
deformities have always been present. Wars were often the cause of 
traumatic amputation. Amputation was & is still used as a judicial 
punishment (21). Ancient cultures have knowledge of amputation for diseases 
such as gangrene, leprosy and ergotism (21). Amputation was feared more 
than death because of it is problems of wound healing, sepsis and mortality. 
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Around 400 B.C Hippocrates provided a classic description of the 
amputation of extremity in a patient who was most likely a diabetic- a 
painless amputation (peripheral neuropathy) of a gangrenous limb with little 
or no bleeding (peripheral vascular disease). (22) Hippocrates (460 - 377) 
also advocated that the ablation of gangrenous tissue should be through the 
gangrenous part. The use of ligature to tie of bleeder was originally put forth 
by Hippocrates (18).  Celsus (25 B.C - A.D 5) described a circular 
amputation technique through healthy tissue, between sound and diseased 
tissue and also described ligation of blood vessels to stop bleeding(21). 
During the dark ages as their name implies, a time in which there was 
little scientific illumination, primitive techniques such as crushing the limb, 
dipping in hot oil or cutting with hot irons were used. The guillotine 
technique was used and the limb surface was allowed to granulate. Speed 
was of the essence. Most people died of blood loss, and those who didn't 
usually succumbed to infection from dirty surgical techniques. Pus was not 
only expected, but also thought of as an indication of normal healing (23). 
In 1517 Han Von Gersdoff of Strasbourg recommended the use of 
tourniquet with compression from a cow or pig bladder, cautery and dressing 
with warm rather than boiling oil (24). 
 The greatest contribution to amputation surgery was made by 
Amhroise Pare (1510-1590), a French army barber-surgeon. He 
reintroduced the use of linen ligature originally put forth by Celsus and 
Hippocrates, when he ran out of cautery oil, during battle surgery. Time was 
still a limiting factor. A surgeon working with no anesthesia, tourniquet, or 
skilled aid hand, was limited to 30 seconds to amputate, and 3 minutes to 
complete the operation. There was no enough time for the surgeon to ligate 
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blood vessels and this is why Guillemeau, Pare student, again abandoned 
this method for direct cautery. Pare also invented upper & lower extremity 
prosthesis (25). 
In 1593 Wilhelm Fabry, the first educated and scientific German 
surgeon popularized the use of linen ligature (24). In 1599 William Clows, 
described the above knee amputation, and in 1669 Pierre Verudin, described 
in detail the below knee amputation. In 1679 Clowdham of Exeter 
introduced the method of flap amputation making closure easy (23). 
James Syme, chief of surgery at the University of Glasgow, Scotland 
performed his first innovative ankle disarticulation in 1842, and was 
followed by Pigoroff (Russian surgeon) with his own version in 1854. 
Rocco Gritty of Milan described knee disarticulation using the patella as a 
protective flap in 1857(24). 
 Still with all the advancement, a patient was susceptible to infection. 
In 1842 Paris hospitals were said to have a mortality of 26%. Mortality after 
amputation even of a digit was high. It was said that it was safer to have a 
limb amputated by gunfire than by a surgeon. As late as 1880, surgery 
assistant held sutures in their mouth (24). 
The invention of tourniquet, anesthesia, analgesia, blood transfusion 
and antibiotics brought amputation to the modern era and made amputation 
an accepted curative maneuver rather than a last ditch effort to safe life. The 
surgeon had time to make residual limbs more functional, and therefore 
allowed the prosthetist to make better prosthesis. 
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The history of diabetes 
 
Diabetes: Historical background: 
 Diabetes is one of many common diseases known long time ago. The 
earliest known record of diabetes was mentioned on Egyptian papyrus by 
physician Hesy Ra (1552-B.C); mention polyuria as a symptom (26). In the 
first century A.D Arateus of Cappodiocia described diabetes as the melting 
down of flesh and limbs into urine. About the same time  
(164-A.D) Galen a Greek physician of Pergamum mistakenly attributed this 
disease to the inability of the kidneys to retain water, so that it passed 
through unchanged (27).  
 The first account of sweet urine was probably reported from India 
about 500A.D (27). Up to the eleventh century, diabetes was commonly 
diagnosed by water tasters, who drank the urine of those suspected of having 
diabetes. The Latin word mellitus (means honey) was added to the term 
diabetes as a result. 
 In the second half of the eighteenth century, significant advances were 
made. Robert Wyatt found a sugar- like substance in urine after evaporation. 
In the same period Frank classified the disease into two forms: diabetes 
insipidus (or spurious) in which there was no sugar in urine or diabetes 
mellitus (or Vera) in which the urine contained sugar. 
 Mc Gregor and Magendie separately found sugar, both in the blood 
of diabetics and in small quantities in blood from normal subjects. More 
detailed Knowledge of the metabolism of sugar has to await the studies of 
Claude Bernard a French researcher. 
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In 1869 Paul Langerhans (27), a German medical student announces 
in dissertation that the pancreas contains two systems of cells. One set 
secretes normal pancreatic Juice; the function of the other was unknown. 
Several years later these cells were identified as the islets of Langerhans.  
 In 1889 Oskar Minkowski and Joseph Von Mering at the University 
of Strasbourg, Austria first, removed the pancreas from a dog to determine 
the effect of an absent pancreas on digestion .At the same time it was 
observed that ablation of the pancreas with phloridzin was followed by 
glycosuria (27). 
 The link between the pancreas and diabetes was unknown .In 1908 a 
German scientist, George Zuelzer developed the first injectable pancreatic 
extract to suppress glycosuria; however, there were extreme side effects to 
the treatment. In 1892 Lepire proposed that diabetes be due to the absence of 
a glycolytic ferment in the pancreatic juice. In 1900 Opie demonstrated a 
connection between diseases of the islets Langerhans and diabetes. Sharpey 
Schafer in 1910 concluded that, the islands of Langerhans must secrete a 
substance, which regulates carbohydrate metabolism, and proposed the name 
insulin for this hypothetical substance (27).  
 In 1921 Dr. Banting assisted by Best, Collip and Macleod discovered 
insulin. In the same year a depancreatized dog was successfully treated with 
insulin. In 1922 insulin was first tested on a human being,  
a 14 - years old boy, named Leonard Tompson. In 1923 Banting and his 
colleague Prof. Macleod were awarded Noble Prize in medicine 
1944 Standard insulin syringe is developed.               
1955 Oral hypoglycemic drugs were introduced. 
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1959 Two types of diabetes identified (type 1 IDDM) and type II 
(NIDDM). 
1966 First pancreatic transplantation was performed. 
1983 First biosynthetic human insulin was introduced (27). 
 
Pathophysiology of Foot ulceration: 
It is firstly important to appreciate that the etiology of diabetic foot 
disease, (infection, ulceration and/or destruction of deep tissue, associated 
with neurological abnormalities and various degrees of peripheral vascular 
disease in the lower limb), (1) is truly multifactorial. Factors to be considered 
include neuropathy, macro vascular disease, micro vascular disease, 
infection, connective tissue and hematological disturbances. Identification of 
the dominant causative factors is essential in planning treatment, and the 
concept of the neuropathic, the neuro-ischemic and the ischemic foot is very 
useful. In cross sectional, population based studies the proportion of 
neuropathic, neuro-ischemic and ischemic lesion was 55%, 34% and 10% 
respectively. Only 1% of the ulcers were considered not to be diabetes-
related (1). 
 
The natural history of the diabetic foot: 
Edmonds and Foster (1994) have divided the natural history of diabetic 
foot into six stages (28).  
1- Stage one: The foot is normal and not at risk, the patient doesn't have 
the risk factors that render him or her vulnerable to foot ulcers. These 
are neuropathy, ischemia, deformity, callus and edema. 
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2- Stage two: High risk factor, the patient has developed one or more of 
the risk factors for ulceration of the foot. 
3- Stage three: Foot with ulcer. The foot has a skin breakdown. 
Ulceration is on the plantar surface in the neuropathic foot and on the 
margin in neuro-ischemic foot. 
4- Stage four: Foot with cellulitis. The ulcer has developed infection 
with the presence of cellulitis, which can complicate both 
neuropathic and neuroischemic foot. 
5- Stage five: Foot with necrosis. Necrosis has supervened. In the 
neuropathic foot infection is usually the cause. In neuro-ischemic 
foot infection is still the most common reason for tissues destruction, 
although ischemia also contributes. 
6- Stage six: The foot can not be saved, and will need major amputation. 
 
Historical background: 
 The association between diabetes and symptoms in the lower limb 
was first recognized by John Rollo (1798). His patients had pain and 
paraesthesia. Indeed before 1850, the frequency of neurological changes 
in diabetic led to suggestion that neuropathy was a cause of diabetes (26). 
 Oakley et al. (29) in 1956 drew attention to the importance of peripheral 
neuropathy as a cause of plantar ulceration and described the three 
factors, arterial disease, neuropathy and sepsis as being essential causes 
of foot lesions in diabetics. This concept was extended by Duplessis who 
emphasized the importance of inter-relationship between three principal 
etiological factors-vascular disease, hematological changes and 
neuropathy-and development of lesion, in the diabetic foot(26). In 1959- 
vascular disease rose to prominence as a principal etiological factor in 
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diabetic foot ulceration following the publication of a paper that 
retrospectively examined amputated limbs from diabetic patient. A 
material that stained positive with periodic acid -Schiff reaction was 
found to fill the arteriole, in the specimen studied (30). In this study 
Goldenberg et al (1959) found no clear difference, in the distribution and 
severity of atherosclerosis in amputated limbs (30). This may be because 
limbs, which require amputation, whatever the cause, are likely to have 
severely diseased arteries. 
The Epidemiology of the Diabetic foot: 
 The point prevalence of foot ulcers in developed countries has been 
estimated to be approximately 4-10% of diabetic individual. A 
corresponding incident of 2, 2 - 5, 9% has also been reported (1). Diabetic 
foot complication, account for up to 25% of diabetes related hospital 
admissions in the United States and Great Britain (4). Foot ulcers are 
documented to precede approximately 85% of all diabetic amputations (1). 
 Numerous factors have been suggested to be related to the 
development of food ulcers. There is a general agreement that the most 
important risk factor for developing a foot ulcer is the presence of Peripheral 
sensorimotor neuropathy (1). 
Diabetic neuropathy: 
 Diabetic neuropathy is defined as the presence of symptoms and/ or 
signs of peripheral nerve dysfunction in people with diabetes after exclusion 
of other causes (1). 60% to 70% of diabetic patients have neuropathy. 
Diabetic neuropathy can be further classified according to the clinical 
manifestations into sensorimotor and peripheral sympathetic neuropathy. 
13 
 
Causes of neuropathy: 
 There are essentially two theories as to the causation of diabetic 
peripheral neuropathy. One related to metabolic factors and the other 
associated with micro vascular disease (31, 32). 
 
Effects of neuropathy: 
1. Extrinsic neuropathic foot ulceration. Loss of somatic sensation over 
the plantar aspect of the food can lead to extrinsic neuropathic foot 
ulceration following trauma. The trauma can be varied- ill-fitting 
footwear, thermal, foreign bodies in shoes and toenail cutting are 
merely examples. The initial trauma is often minor, but in the absence 
of somatic sensation it is not perceived, so allowing tissue damage to 
continue, once started. 
2. Intrinsic neuropathic foot ulceration. The etiology here is more 
complex. Somatic motor neuropathy result in weakness of the intrinsic 
muscle of the foot which in turn allows abnormal movements of the 
small bones of the foot and Joint subluxation occurs. Ligament and 
Joint capsules are stretched further and the bony structure of the foot 
is altered permanently. 
 As time goes on, these changes lead to foot deformities such as a claw 
foot with prominent metatarsal heads, or a rocker bottom foot with collapse 
of the longitudinal arch and prominence of the tarsal bones. These bony 
changes produce Localized areas of high pressure on the sole of the foot, 
particularly under the metatarsal heads, on the tips of toes, on the heel and 
under the midfoot. These high-pressure areas are associated with ulceration. 
Autonomic neuropathy: 
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 It causes loss of normal sweating, so that the skin become, dry, scaly 
and stiff, leading to formation of fissures through the dermis that serve as 
portal of infection. Sweat contains keratinolytic enzymes, which help break 
down hyperkeratotic areas. In the absence of sweating, the skin becomes 
inelastic and more prone to trauma. 
Clinical manifestation and assessment of diabetic neuropathy: 
 Symptoms of peripheral neuropathy include burning pain, stabbing 
pain, paraesthesia, hot and cold sensation, and hyperesthesia: all symptoms 
prone to nocturnal exacerbation. 
 Signs include reduced sensation to pain, temperature, vibration, small 
muscle wasting, absent sweating and distended dorsal foot veins. 
 Neuropathy can be tested by the traditional clinical methods 
examining the various sensory modalities, muscle power and knee and ankle 
reflexes. More reproducible and meaningful information can be collected by 
the nylon monofilament. 
 The Semmes Weinstien l0g monofilament is pressed onto the skin of 
the foot until it buckles. If the patient is unable to feel this, then it is assumed 
that protective sensation is lost (1). 
 The vibratory sense can be tested using a 128 HZ tuning fork or better 
still by a biosthesiometer. Pain sensation can be tested by a pin brick and 
deep sensation by a tendon hammer. 
Peripheral vascular disease and diabetes: 
 Peripheral vascular disease (PVD), causing arterial insufficiency, is 
the most important factor related to the outcome of a diabetic foot ulcer in 
diabetic patients (1). Atherosclerosis and medial sclerosis are the most 
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common arterial diseases. Atherosclerosis causes Ischemia by arterial 
narrowing and blockage. Medial sclerosis (Moenckeberg sclerosis) is 
calcification of the tunica media producing a rigid conduit without, however, 
encroachment on the arterial lumen. 
There is no peripheral arterial lesion specific to diabetes, but the 
pattern of atherosclerosis is somewhat different. The characteristics of 
atherosclerosis in diabetic patients as opposed to non- diabetic patients (1) : 
1. More common. 
2. Affect younger individuals. 
3. No sex difference.                                                                    
4. Multisegmental. 
5. More distal. 
Symptoms:  
 When adequate collateral vessels compensate for arterial occlusion, 
there may be no symptoms at rest, but when the demand for blood flow 
increases, claudication may occur. End stage symptoms are rest pain and 
ulceration/ gangrene. There are thus four stages according to Fontaine (1):  
 Stage 1:  Occlusive arterial disease without clinical symptoms. 
 Stage 2:  Intermittent claudication. 
 Stage 3:  Ischemic pain. 
 Stage 4:  Ulceration-gangrene. 
 
Clinical examination: 
 Experts recommend that the vascular status in diabetic patient should 
be examined on an annual basis paying particular attention to: (1) 
1. A history of intermittent claudication or ischemic rest pain. 
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2. Palpation of pulses of the posterior tibial and dorsalis pedis is 
mandatory. If pulse is absent, the popliteal and femoral pulsation 
should be examined. If foot pulses are present significant vascular 
disease is unlikely. The dorsalis pedis artery may be congenitally 
absent. When pedal pulses are absent, ankle blood pressure should be 
measured with a hand-held ultrasound Doppler device. An ankle 
brachial index (ABI) below 0.9 indicates occlusive disease. 
3.   Potential   signs   of critical   ischemia   e.g.   Skin   necrosis   and 
gangrene.  
Chronic critical ischemia: 
 Critical ischemia indicates risk of amputation of a major part of the limb, 
unless reversed by a revascularization procedure. Chronic critical ischemia is 
currently defined by either one of two of the following criteria (1): 
1- Persistent ischemic rest pain requiring analgesia for more than two 
weeks. 
2- Ulceration or gangrene of the foot or toes, both associated with an 
ankle systolic pressure of < 50 mm Hg, or a toe systolic pressure  
of < 30mm Hg.  
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Non invasive vascular testing: 
 The commonly used techniques include ankle pressure, toe pressure 
and less frequently transcutaneous oxygen pressure measurements. Any 
measurement less than the following values is considered abnormal  
(0.8, 45 mmHg, 40 mmHg) for the above mentioned test respectively (33). 
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Major Amputations of the lower extremity 
 
General surgical principles: 
 Today amputation has come to be regarded as a form of treatment and 
not a purely life saving procedure. It is a carefully planned operation, which 
is followed by intensive rehabilitation, medically, vocationally and socially 
so that the amputee can adopt the use of the prosthesis and the significant 
alteration of body image. Meticulous attention to the detail and gentle 
handling of tissues are important for creating a well healed and highly 
functional amputation stump. 
The stump: 
 This has been defined by Day H J (1980), as being the terminal 
segment remaining after amputation (34). Day's criteria for a healthy and 
efficient stump are as follows: 
1. Well nourished skin with a healed pain free mobile scar. 
2. Rounded bone ends, stabilized by strong balanced muscles, with well-
protected high nerve endings. 
1. 3. Proximal   joints   should   be   normally   mobile   and   without   
any contracture. 
Tourniquet: 
 The use of tourniquet is contraindicated in major amputations of the 
lower extremity in diabetic because these limbs are ischemic and infected(35). 
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Level of amputation: 
 In remote past amputation through specific levels was necessary for 
proper prosthetic fitting. With modern types of prosthesis and sophisticated 
prosthetic - fitting technique, the level of amputation is less important. 
Rather, any well-healed, non-tender, and properly constructed amputation 
stump can now be satisfactorily fitted with prosthesis. The amputation 
should be through tissues that will heal satisfactorily and at a level that will 
remove the diseased or otherwise abnormal part. The cardinal rule is to 
preserve all possible length consistent with good surgical judgment (20). 
Skin flaps: 
 Regardless of the level of amputation, the stump should be covered 
with good skin. The skin should be mobile and normally sensate. Atypical 
flaps should always be preferred to amputation at a more proximal level. The 
location of the scar is rarely important with modern total - contact prosthetic 
sockets, but the scar should not be adherent to the underlying bone because 
adherent scars make prosthetic fitting extremely difficult and because this 
type of scar often breaks after prolonged prosthetic use (20). 
Muscles: 
 The muscles should be divided just distal to the level of intended bone 
section. It should be pointed out that myodesis is specifically contraindicated 
in diabetic patients with peripheral vascular disease or ischemia. Beveling or 
other contouring of the muscles may be necessary to obtain a stump that is 
shaped properly (20). 
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Nerves:  
 Most surgeons currently agree that nerves are best treated when 
isolated, gently pulled distally into the wound, and divided cleanly with a 
sharp knife so that the cut end will retract well proximal to the level of bone 
section. Strong tension on the nerve should be avoided during this maneuver. 
Large nerves contain relatively large arteries and should be ligated before 
being divided (35). 
Blood vessels: 
 Major blood vessels should be isolated and individually ligated with 
absorbable or non-absorbable sutures before being divided. The larger ones 
should be doubly ligated (20). 
Bone: 
 Excessive periosteal stripping is contraindicated and may result in the 
formation of ring Sequestrum. Bony prominence should always be resected. 
This is especially important in locations such as the anterior aspect of the 
tibia in transtibial amputation. Hampton (1972) (20) has pointed out the need 
for beveling the lateral aspect of the femur in transfemoral amputation. 
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Situation in Sudan 
 
 In Sudan despite the fact that amputation is a common surgical 
procedure, there is little published data. The subject of diabetic septic foot 
was first studied by Ahmed-M.E (36). He found that the incidence of major 
limb amputation rate of (DSF) is (38%). Mohamed I A, et al in 1994, found 
that diabetic septic foot is the main cause of major lower amputation 
comprising (24.1%) (37). Ali EA, et al (22), in 1999, studied prospectively the 
clinical presentation, management and outcome of 150 patients presenting to 
(KTH) with (DSF). 59 patients (39.3%) underwent major lower limb 
amputation. 
22 
 
 
1.3 OBJECTIVES 
 
1. To study the indications and anatomical levels of major lower Limb 
amputations in diabetic patients in KTH and Gabir Abu Izz Center. 
2. To identify: 
a- The healing patterns of major lower limb amputation at 
various levels  
b- The rate of postoperative stump infection. 
c- The rate of reoperation. 
d- The in hospital mortality and mean hospital stay. 
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Chapter Two  
Patients & Methods  
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PATIENTS AND METHODS 
 
 This is a prospective analytic hospital based study on the clinical 
patterns of major lower limb amputation in diabetics. 
 This study was performed in 70 patients with diabetes, who 
underwent major lower limb amputation in KTH and Gabir Abu Izz 
Specialized Center for Diabetes, during the period between July 2002 and 
January 2003. The aims and methodology of the study were explained to the 
patients, and their consent was obtained. 
 Patient data were collected using a unified clinical protocol of 
database consisting of a questionnaire, clinical examination and 
investigations (appendix 1). 
The clinical protocol included:  
 
A- Patients' personal data.  
B-   History: 
i. Type of diabetes. 
ii. Duration of diabetes. 
iii. Mode of control of diabetes. 
iv. Compliance. 
v. History of previous foot education. 
vi. History of hypertension and smoking. 
vii. History of previous foot ulceration.  
viii. viii. History of previous amputation.  
 
24 
 
 
C-   Amputation surgery: 
The   following   data   concerning   the   amputation   surgery   were 
recorded for each patient:  
(i) Date. 
(ii) Caliber of the surgeon. 
(iii) Anatomical level and dexterity. 
(iv) Type of anesthesia. 
(v) Indication for amputation. 
(vi) Wound management. 
(vii) Use of drains. 
 
D-   Investigations: 
a- The following investigations were done for each patient 
preoperatively and their results were obtained from the records 
of the patients : 
(i) Hb. 
(ii) RBS. 
(iii) FBS. 
(iv) 2-hour postprandial blood glucose. 
(v) Blood urea. 
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b- The following investigations were done for some patients 
preoperatively and their results were obtained from their 
records: 
(i) Serum creatinine. 
(ii) Radiological studies for the affected limb. 
(iii) Microbiological studies in the form of wound swab 
for culture and sensitivity from the foot ulcer 
before surgery. 
 
c- The following postoperative events were recorded:- 
1. Post operative complication. 
2. Microbiological studies in the form of wound swab for 
culture and sensitivity from the stump in-patients who 
developed postoperative wound infection. 
3. Pattern of wound healing after amputation at different 
levels. 
4. Requirement and indication of re-operation.  
5. Development of contralateral  lower limb ulceration.  
6. Duration of hospital stay.  
7. Causes and circumstances of death. 
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RESULTS 
 
 A total of 70 diabetic patients underwent major lower limb 
amputation, between July 2002 and January 2003, at KTH and Gabir Abu El 
Izz center. Forty-nine patients (70%) were seen in KTH and twenty-one 
patients (30%) were seen in Gabir Abu El Izz center. 
 This group comprised 28 females (40%) and 42 males (60%). The 
male to female ratio was 1.5: 1. The level of lower limb amputation did not 
differ significantly between males and females (P=0.655) (Figure 1). 
 Their age ranged between 35 and 92 years. The mean age was 61.5 
±11.85 years. Fifty-six patients (79.99%) were in the age group 50-80 years 
(Table 1). The age in years was not significantly related to the level of 
amputation (P=0.097) (Figure 2). 
 Sixty-seven patients (95.72%) were having NIDDM, three patients 
(4.28%) were having IDDM, and the ratio of NIDDM to IDDM was 22.3:1. 
Sixty-one patients (87.15%) had diabetes for more than 10 years. 
Twenty-nine patients (41.42%) had diabetes for 10-19 years. The mean 
duration of diabetes was 18.3 ± SD =9.04 years. All patients were known 
diabetics; no newly diagnosed diabetics were reported in this series  
(Table 2). In this series the level of LEA was not found to correlate 
significantly with the duration of the disease (Figure 3). 
 The diabetes was controlled by oral hypoglycemic drugs in 64 patients 
(92%), by insulin in 3 patients (4%) and by diet only in 3 patients (4%). 
However all patients were shifted to soluble insulin. 
The majority of patients 51 (72.86%) were found to be irregular in 
their treatment.  
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History of hypertension was obtained in 11 patients (16%). Thirteen 
patients (19%) were regular smokers. Three patients were current smokers, 
while 10 patients already stopped smoking. Hypertension was significantly 
more prevalent among transfemoral amputees compared to transtibial 
amputees (P=0.017) (Figure 4). On the other hand no significant correlation 
was encountered between smoking and the level of amputation (P=0.345) 
(Figure 5). 
Ten patients (14%) had previous foot education, while 60 patients 
(86%) did not have previous foot education. 
There was a past history of previous foot ulceration in thirty patients 
(42.85%). Thirty-one patients (44%) had history of previous minor and /or 
major LEA. The previous LEA was ipsilateral, contralateral and bilateral in 
20 (64.51%), 7(22.58%) and 4 (12.91%) patients respectively (Figure 6). 
History of previous ulceration and / or amputation was not found to correlate 
significantly with the level of LEA in this series (P= O.693) (Figure 7, 8). 
Forty-seven LEAs (67.15%) were done by surgical registrars and 23 
LEAs (32.85%) were done by consultants. 
The majority of the LEAs forty-seven (67%) were done under spinal 
anesthesia, Nineteen (27%) were done under general anesthesia and only 4 
(6%) were done under local anesthesia. 
Seventy patients underwent major LEAs. Fifty-two patients (74.28%) 
had transtibial amputations and 18 patients (25.72%) had transfemoral 
amputations. No Symes, through knee or hip disarticulation were 
encountered in this series (Figure 9). Of the seventy major LEAs, the 
majority 42 (60.0%) were on the left side, whereas 28 (40.0%) were on the 
right side (Figure 9). 
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In fifty-six patients (80%) the indication for LEA was control of 
sepsis. This was followed by ischemia in 31 patients (44.2%) and extensive 
tissue loss in thirteen (18.55%) patients (Figure 10). The indication of LEA 
according to the anatomical level is illustrated in (Table 3). 
Information about glycemic control before amputation was obtained 
by reviewing the results of measurement random blood sugar (RBS), fasting 
blood sugar (FBS) and 2 hour postprandial (2HPP). Accordingly only (1%, 
4%, 4%) had good glycemic control (Figure 11, 12and 13). 
Preoperative investigations from patient’s records showed that 35 patients 
(50.0%) had Hb level below 10-g / dl. 
The results of preoperative microbiological studies were obtained 
from the patients' records. These were in the form of wound swab for culture 
and sensitivity and were done in 44 patients (62.85%). The swab was taken 
from the infected ulcer before surgery. The most frequent isolates were 
staphylococcus aureus in twenty-two patients (50.00%), followed by Gram 
negative organisms in 17 (38.64%) patients and in three cases (4.45%) no 
growth was obtained (Figure 14). Twenty-four (54%) isolated organisms 
were found sensitive to ciprofloxacin. 15 isolates (36.6%) were sensitive to 
Gentamycin and 13 isolates (31.7%) were sensitive to Amikacin (Figure 15). 
The results of preoperative renal function assessment by measuring 
the blood urea & serum creatinine level were obtained from patients' 
records. Only 7 (10.0 %) patients had creatinine level above 1.5 mg/dl. 
Preoperative radiological investigations were done in thirty-four 
patients (48.57%). The most frequently diagnosed radiological abnormalities 
were periosteal reactions, cortical erosions and radiolucent areas (Figure 16). 
29 
 
The wound was closed primarily in Sixty-one patients (87.14%) and 
was left open in 9 patients (12.86%). The wound was closed without a drain 
in 56 patients, (80%) and with a drain in 5 patients (20%). 
The most frequently encountered post operative complication was 
wound infection in 11 patients (15.71%), followed by ischemia of the stump 
in 6 (8.56%) patients (Figure 17). The rate of postoperative complication 
was significantly higher in patients undergoing transfemoral amputation 
(P=0.04) (Table 4).  
Wound healing occurred primarily in the majority of patients forty-
five (64.29%). Fourteen patients (20.00%) died before the occurrence of 
wound .healing. Wound healing occurred after debridement in 6 patients 
(8.56%), after delayed suturing in 1 patient (1.42%) and after refashioning in 
one (1.42%) patient (Figure 18). The difference in the rate of primary 
healing in transtibial (76.9%) and transfemoral (27.78%) amputation was 
found to be statistically significant (P=0.000) (Table 5). 
From the eleven patients who developed postoperative wound 
infection staph was isolated from 4 patients, Gram-ve organisms from 3 
patients. No microbiological studies were done in the remaining 4 cases 
(Table 6). 
Nineteen patients (27.14%) required reoperation. The most frequent 
type of reoperation was debridement in 16 patients (21.86%). The 
requirement of reoperation was significantly higher among transfemoral 
(55.6%) over transtibial amputees (17.4%) (P=0.008) (Table 7). 
Fourteen patients (20.0%) died in hospital. The most common causes 
of death were septicemia and MOF in 10 patients followed by myocardial 
infarction in 3 patients and uremia in 1 patient (Table 8). The mortality rate 
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for transfemoral amputation (50.00%) was statistically higher than that of 
transtibial amputation (9.62%) (P= 0.000) (Figure 19, Table 8). 
Three patients developed contralateral lower limb ulceration while in 
hospital. This was managed by debridement in two cases and by a transtibial 
amputation in one case. 
Forty-six patients (65.9%) stayed in hospital for 10-40 days. The 
mean hospital stay was 30.14 ± SD -21.87 days (Table 9). No significant 
difference in the hospital stay according to the level of LEA was noted in 
this series (P=0.497) (Table 10). 
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Table (1) Age distribution of diabetic patients who underwent major LEA (n= 70). 
 
Age in Years Number of patients 
31 – 40  2   (2.86%) 
41 – 50  8   (11.43%) 
51 – 60  20 (28.57%) 
61 – 70  18 (25.71%) 
71 – 80  18 (25.71%) 
81 – 90  3   (4.29%) 
91 – 100  1 (1.42%) 
    
Mean age = 61.5 ± 11.85 years 
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Table (2) Duration of diabetes in patients who underwent major LEA (n= 70). 
 
Age in Years Numbers of patients 
  1 – 10  9   (12.85%) 
11 – 20  29 (41.42%) 
21 –  30  20 (28.57%) 
31 – 40  11  ( 15.71) 
41– 50  1   (01.45) 
 
Mean duration of diabetes = 18.3 ± 9.04 years  
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Table (3) Level of LEA in relation to indications of LEA in diabetic patients who 
underwent major LEA (n =70). 
 
Levels of LEA  Indications of LEA  
Transtibial  Transfemoral 
Total  
Extensive tissue loss  1 (1.42%) 0 (.00%) 1 
Ischemia  4 (5.71%) 9 (12.86%) 13 
Control of sepsis  26 (37.14%) 1 (1.43 %) 27 
Ischemia + control of sepsis  11 (15.71 %) 6 (8.57%) 17 
Extensive tissue loss + control of sepsis  9 (12.86% ) 2 (2.85%) 11 
Extensive tissue loss + control of sepsis  + Ischemia  1 (1.43%) 0  (0.00) 1 
Total  52 18 70 
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Table (4) Level of LEA in relation to types of post operative complications in diabetic patients who 
underwent major LEA (n= 20) . 
 
Levels of LEA  Indications of LEA  
Transtibial  Transfemoral 
Bleeding  1 (5%) 0 (0%) 
Wound infection  6 (30%) 5 (25%) 
Ischemic stump  0 (0%) 3 (15%) 
Septicemia  1 (5%) 1 (5%) 
Wound infection + ischemia  1 (5%) 2 (10%) 
Total  9 11 
 
 P value = 0.371  
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Table (5) Level of LEA in relation to wound healing after amputation in diabetic patients who underwent 
major LEA (n = 70) . 
  
Levels of LEA  Indications of LEA  
Transtibial  Transfemoral 
Total  
Occurred primary  40 (57.14%) 5 (7.14%) 45 
Occurred after refashioning  0 (0.00%) 1 (1.42%) 1 
Patient died before healing  4 (5.71%) 8 (11.42% 12 
Didn’t occur by the end of the observation period   1 (42% ) 2 (2.85%) 3 
Occurred after debridement   4 (5.71% ) 2 (285%) 6 
Occurred after delayed suturing  3 ( 4.28% ) 0 (0.00%) 3 
Total  52 18 70 
 
P value < 0.000 
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Table (6) Isolated organisms from diabetic patients who developed stump infection following major LEA 
(n=11). 
 
Age in Years Numbers of patients 
  Staph.   4 (5.71%) 
Coliform  2 (2.85%) 
Proteus  1 (1.43%) 
Not done  4 (5.71%) 
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Table (7) Level of LEA in relation to requirements & types of reoperation in diabetic patients who 
underwent major LEA (n = 70). 
 
Levels of LEA  Requirement and types of reoperation   
Transtibial  Transfemoral 
Total  
Debridement  8 (11.42%) 8 (11.24%) 16
Refashioning  0 (0.00%) 1 (1.42%) 1 
Proximal major amputation  0. (0.00%) 1 (1.42%) 1 
 
Yes 
Others  1 (1.42%) 0 (0.00%) 1 
 
 
19 
           No  43 (61.42%) 8 (11.42%) 51 51 
Total  52 (74.66%) 18 (25.34%) 70 70 
 
 P value < 0.008  
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Table (8) Level of LEA in relation to causes of death in diabetic patients who 
underwent major LEA (n = 14). 
  
Levels of LEA  Indications of LEA  
Transtibial  Transfemoral 
Total  
Septicemia & MOF  3 (21.43 %) 7 (50.00%) 10 
Myocardial infarction  1 (7.14%) 2 (14.28%) 3 
Uremia  1 (7.14%) 0 (0.00%) 1 
Total  5 9 14 
 
 P value = 0.3377  
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Table (9) The duration of hospital stay in days in diabetic patients who 
underwent major LEA ( n = 70) 
Hospital stay in days  No. of patients  
1-10   7 (10.00%)  
11 – 20  19 (27.14%)  
21 – 30  18 (25.71%)  
31 – 40  9 (12.85%)  
41 – 50  5 (7.14%)  
51 – 60  5 (7.14%)  
61 – 70  0 (0.00%)  
71 – 80  2 (2.85%)  
81 – 90  2 (2.85%)  
91 – 100  3 (4.28%)  
Total      70  
 
40 
 
Mean hospital stay is 30.14 ± SD 21.87 days 
Table (10) Level of LEA in relation to hospital stay in days in diabetic  
patients who underwent major LEA ( n = 70). 
Levels of LEA  Indications of LEA  
Transtibial  Transfemoral 
Total  
1-11  4 (5.71%) 3 (4.28%) 7 
11 – 20  16 (22.85%) 3 (4.28%) 19 
21 – 30  15 (21.42% 3 (4.28%) 18 
31 – 40  7 (10.00%) 2 (2.28%) 9 
41 – 50  3 (4.28%) 2 (2.28%) 5 
51 – 60  4 (53.71 %) 1 (1.42%) 5 
61 – 70  0 (0.00%) 0 (0.00%) 0 
71 – 80  1 (1.42%) 1 (1.42%) 2 
81 – 90  1 (1.42%) 1 (1.42%) 2 
91 – 100  1 (1.42%) 2 (2.28%) 3 
Total  52 18 70 
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                       P value = 0.497 
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4.1 DISCUSSION 
 
The major adverse outcome of diabetic foot problems, are foot 
ulcers and amputation. Diabetic foot complications are the most common 
cause of major LEA in Sudan, accounting for (24.1%) (37).The risk of lower 
extremity amputation is 15 to 46 times higher in diabetics than in 
nondiabetics (38). Major amputations are associated with a high mortality 
rate (39). Recent studies have shown that very few amputees from (12%-26 
%) achieve normal mobility (40). 
This prospective analytic hospital-based study included seventy 
diabetic patients who underwent major LEA in KTH and Gabir Abu El 
Izz diabetes center in the period July 2002 - January 2003. 
The male to female ratio in this series was (1.5: 1). Ebskov B et al(41) 
in a series of 2848 major LEAs in diabetic individuals reported a similar 
ratio of (1.18:1). A higher ratio of (2.2:1) was reported by Turney BW et 
al(42). A sex difference in diabetes-related major lower limb amputation 
rates of (2:1) was reported by Armstrong D G et al (43). A ratio of (2.6:1) 
was reported from KTH for forty diabetic patients with transtibial 
amputation by Mohammed IM et al (26). The slight male predominance in 
our series can be explained by the fact that male have a more active 
lifestyle and therefore have a high risk of foot injuries. Furthermore, males 
sex has been associated with increased risk of foot ulcer and amputation in 
most studies of type 2-diabetes (1). 
Although more diabetic males were encountered in our series, the 
level of lower limb amputation did not differ significantly between males 
and females (P = 0.655). 
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The age of our patients ranged between thirty-five and ninety- two 
years. The mean age was 61.1years ± SD 11.85. Eighty percent of our 
patients were in the age group (50-80) years. 
The mean age for diabetic amputees reported from the west ranged 
between (64.1- 70.9) years (44, 45, 46). This is a marked age difference. 
Similar age discrepancies were reported by other workers from this 
country (37-27). This can be partly explained by the fact that diabetic patients 
in western communities are more aware of the control and treatment of 
diabetes, and therefore they lose limbs from diabetic sepsis at a much older 
age if that becomes necessary. Moreover, the widespread implementation 
of arterial reconstruction resulted in a substantial decrease (40-80%) in 
amputation rates in western communities (46). 
The age in years was not significantly related to the level of LEA in 
our series (P = 0.097). This may be difficult to explain, because with the 
advancement of age, the effects of diabetes on the feet, and peripheral 
vascular disease become more evident. But during the last 3 decades there 
is a growing tendency to preserve the knee joint even in elderly diabetic 
patients with peripheral vascular disease (20). This tendency is based on two 
reasons, one: preservation of the knee joint is very important in 
postoperative rehabilitation (20), two: after amputation through the LE for 
PVD with diabetes, the stump usually heal even when the level of 
amputation is below the knee (20). 
Sixty-seven patients (95.72%) were having NIDDM, 3 patients 
(4.28%) were having IDDM.A similar ratio among diabetic amputees 
(with NIDDM comprising 93%) were reported by Morris AD et al (47). 
NIDDM accounts for 66.1% - 84.6% of diabetes in Sudan (48, 49). This 
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predominance of NIDDM among our patients is consistent with the fact 
that patients with NIDDM are more prone to develop foot ulceration and 
LEA (50, 51). 
The duration of diabetes in our patients ranged from 1 to 40 years. 
The mean duration of diabetes was 18.3 year ± SD 9.04. The majority of 
our patients (87.15%) had the disease for more than 10 years .It is known 
that, the longer the duration of diabetes, the higher is the degree of 
neuropathy, which is the main cause of foot sepsis (52). Humphrey  
AR et al (53) reported that LEAs are associated significantly with longer 
mean duration of diabetes. 
In our series the level of LEA was not found to correlate 
significantly with the duration of the disease (P= 0.206). No newly 
diagnosed diabetics were encountered in this series, in contrast to other 
workers who reported that in up to (15%- 19%) of diabetic patients 
undergoing major LEA, diabetes was first diagnosed at the time of 
surgery. 
Fifteen percent of our patients were hypertensive. The prevalence of 
hypertension among Sudanese diabetic patients undergoing major LEA is 
not available. Ali SM et al (54) reported systemic hypertension in (18%) of 
patients presenting to KTH with diabetic foot sepsis (n = 150). Allaham 
YR et al (50) studied the risk factors for development of diabetic foot in a 
symptomatic Sudanese diabetic patients and they reported systemic 
hypertension in twenty-five percent of their patients (n= 100). 
Hypertension was less prevalent in our series, but it was significantly more 
prevalent among transfemoral amputees compared to the transtibial 
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amputees (P= 0.017). This is very interesting, since hypertension is a 
potentially modifiable risk factor. 
 Thirteen patients in our series were regular smokers (18.6%). This 
Figure is lower than that reported by Mohamed IM et al (26), which was 
(35%). Smoking was not significantly related to the level of LEA in our 
patients (P=0.345). Moss SE et al (55) and Selby JV et al (56) reported 
similar results. 
 Eighty-six percent of our patients did not have any previous foot 
education. Relatively little research has been performed into the specific 
effect of education on the incidence of ulcers and amputations in diabetic 
subjects. Although some studies suggested that education results in a 
reduction of ulcers and amputations, in most of these studies education was 
in fact part of a comprehensive foot-care program (1). Ezio F et al (57) 
reported that the use of therapeutic shoes and intense educational training 
have contributed to the low incidence of new ulceration and major 
amputation in their study population 
 To be effective, education should be simple, relevant, consistent and 
repeated. It should also target the high risk groups, patients, and health care 
professionals. Unfortunately inspite of the clear guidelines and 
recommendations incomplete foot examination is reported in up to (50%) 
of patients undergoing LEA (1). 
 Among individuals with diabetes identified in the 1989 US National 
Health Interview Survey, (22%) stated they never checked their feet, and 
(53%) of them reported no foot examination by a health care professional 
within the past six months (58). 
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Forty percent of our patients reported history of previous ulceration 
and /or amputation. This is expected because (85%) of diabetes-related 
LEAs are preceded by a history of foot ulceration (1). It is also known that 
diabetic patients with history of previous ulceration and / or amputation are 
at increased risk of subsequent amputation (59, 60,61).  
History of previous ulceration and / or amputation was not found to 
correlate significantly with the level of LEA in our series (P= 0.693). 
 Preoperative glycemic control was graded as good, moderate and 
bad according to the blood sugar level. Three indices were considered: 
FBS, RBS and 2HPP. Our results showed that (59% -75%) of our patients 
fall into the bad control group according to the three indices combined. 
This is very serious because hyperglycemia together with vascular 
dysfunction is a direct cause of diabetic neuropathy (62). However these in 
the same time highlight potential therapeutic approaches. 
 Preoperative renal function was assessed by measuring blood urea 
and serum creatinine level. (10%) of our patients had creatinine levels 
above 1.5 mg/dl. The prevalence of chronic renal insufficiency in our 
patients is higher than that described by Al Laham YR et al (50) (7%). 
Apelgvist J et al (63) reported a prevalence of diabetic nephropathy of 
(26%). Eggers PW et al (64) reported that amputation rate among diabetic 
patient with end stage renal disease (ESRD) is 10 times higher than that 
among diabetic patients at large. 
 Wound swabs were taken from the infected primary lesion before 
surgery in forty-four patients (62.9 %). The specimen sent was a wound 
swab in all patients. Sapico FL et al (65) reported that cultures obtained by 
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curettage of the base of ulcers correlated better with deep tissue cultures 
than did needle aspiration or swabs of the ulcers. 
 Most of our bacteriological assessment was qualitative rather than 
quantitative i.e. no information about the bacterial count per gram of tissue 
was reported. The drawback of such studies is that it may not differentiate 
between contamination and deep infection. Staphylococcus aureus was 
isolated in (50%) of patients. It was followed in frequency by coliforms 
(38.63%), streptococci in (4.55%) and no growth was obtained in 3 cases 
(6.8%). Jones EW et al (66) in a study of the microbiology of diabetic foot 
lesions, reported staph aureus to be the most frequent incriminated 
organism. 
No anaerobic organisms were reported in our cultures. This is most 
probably due to the lack of special transport media and proper culture 
setup. 
 Radiological assessment before surgery was done on thirty-four 
patients (48.57%). The imaging study used was a plain radiograph. 
Radiographs were obtained in anteroposterior and lateral projections. The 
most frequently diagnosed radiological abnormalities were periosteal 
reactions, cortical erosions and radiolucent areas. No soft tissue gas or 
foreign bodies were encountered in this series. 
 MRI and CT scan although they are important were not done in our 
patients because they are expensive. Morrison WE et al (67) reported that 
MRI may still be needed even if conventional radiographs are diagnostic 
for osteomyelitis, because it demonstrates clearly the extent of infection in 
the bone, and to see if neighboring bones are involved. 
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 Fifty- two patients (74.28%) had transtibial amputation and 18 
patients (25.72%) had transfemoral amputation. No Symes, through knee 
or hip disarticulation were encountered in our series. The ratio of 
transtibial to transfemoral amputation in our patients was (2.9:1). 
 A similar ratio of (3:1) was reported by Ali EA et al (22) (n=59). 
Mohemed I A et al (37) in a series of forty-one diabetic patients with major 
LEA reported a ratio of (1.5: 1). No Symes, through knee or hip 
disarticulation were reported in both series. 
Our ratio is higher compared to that reported by Tourkissian B  
et al (68) which was (1.5:1). Their lower ratio can be explained by the higher 
prevalence of PVD among their patients. 
Dormandy   J et al (69) reported that   transtibial   to   transfemoral 
amputation ratio of (2.5:1) is the minimum acceptable for units providing 
LEA service.  
 The method of anesthesia used in the majority of our patients was 
spinal anesthesia in (67%), followed by general anesthesia in (27%) and 
local anesthesia in (6%). Minchev B et al (70) in series of 296 major LEAs 
reported that the type of anesthesia used were general anesthesia in (55%), 
epidural in (29%) and spinal in (14%). Epidural anesthesia is now gaining 
more grounds because it can provide postoperative analgesia as well. 
 The commonest indication for major LEA in our series was control 
of sepsis in (38.57%); this was followed by ischemia in (18.57), extensive 
tissue loss and sepsis in (24.28%). In the remaining (18.58%) the 
indication was a various combination of ischemia, sepsis and extensive 
tissue loss. 
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 Van Damme H et al (71) in a series of 186 diabetes-related major 
LEAs reported that the most common indications for major amputation 
were extensive tissue loss, intractable infection and non-reconstructable 
occlusive vascular disease. Morris AD et al (47) reported in their series of 
258 non traumatic major LEAs in diabetic patients, infected non healing 
ulcers (31%) and gangrene (29%) as the two main indications for 
amputation. Pecoraro RE et al (4) in a series of (80) consecutive LEAs in 
diabetic subject's reported that (46%) of the LEAs were due to ischemia 
and (59%) were due to infection. 
 The wound after amputation was closed primarily in sixty-one 
patients (87.14%) and was left open in 9 patients (12.86%). Open 
amputation as the name implies, is one in which the skin is not closed (20). 
The operation is only the first of at least two operations required to 
construct a satisfactory stump. The indication of this type of amputation is 
to prevent or eliminate infection (26). The wound was closed without a drain 
in fifty-six patients (80.00%) and with a drain in 5 patients. 
 The most frequently encountered postoperative complication was 
'wound infection in 11 (15.71%) patients, followed by ischemia of the 
stump in (8.5%). The occurrence of postoperative complication was 
significantly related to the level of LEA (P< 0.00). The rate of 
postoperative complications for transfemoral amputation was (61.11%) 
while that for transtibial amputation was (17.3%). Toursarkissian B et al 
(68) in a series of 113 diabetes-related major LEAs reported a postoperative 
complications rate of forty percent. The majority of these were wound-
related (22%). In their series wound complications were more frequent 
with transfemoral than transtibial amputation (P = 0.04). 
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 The requirement of reoperation rate in our series was (27.14 %). The 
most frequent type of reoperation was debridement in (84.2%) followed by 
delayed suturing in (5.3%) refashioning in (5.3%) and a more proximal 
amputation in (5.3%). 
 The requirement of reoperation was significantly higher among 
transfemoral (55.6%) over transtibial amputees (17.4%) (P = 0.008). 
 Primary healing occurred in (76.9 %) of patients who underwent 
transtibial amputation and in (27.78) in those who underwent transfemoral 
amputation. This difference in primary healing patterns was found to be 
statistically significant (P <0.000). Similar healing patterns were reported 
by Dormandy J et al (69). 
 The overall in-hospital mortality in our series was (20%). The 
mortality rate for transfemoral amputation (50%) was statistically higher 
than that of transtibial amputation (9.62%) (P < 0.00). Our mortality rate 
figures are comparable to those reported by the International Working 
Group on the Diabetic Foot: (10-40 %) for transfemoral amputation Vs  
(5 - 20 %) for transtibial amputation (1). The most common causes of death 
were septicemia and multiorgan failure, followed by myocardial infarction 
and uremia. Amputation of the lower limb is generally viewed as an 
ominous event portending poor survival, with four-year survival ranging 
from (22% -76%)(71). Survival is affected by age, level of amputation and 
co-morbid conditions. Jennifer A et al (72) reported a twenty percent 
mortality rate before discharge for patients undergoing transtibial 
amputation. 
 The mean duration of hospital stay in our patient was 30.14 days 
±SD 21.87. This duration is comparable to that reported by Turney BW et 
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al (42). Payne C P (39) studied diabetes related lower limb amputations in 
Australia and reported a mean hospital stay of (24.7 days). A mean 
hospital stay of forty-two days was reported from the Netherlands (73). 
No significant difference in the hospital stay according to the level of LEA 
was noted in our series (P = 0.497). 
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4.2 CONCLULSION 
 
 Major LEA had prevalence upon type II DM. 
 The majority of patients had history of previous ulceration and | or 
minor or major LEA. 
 Most patients had poor glycemic control.  
 Transtibial and transfemoral amputations are the main types of 
major LEA in diabetic patients in KTH and Gabir Abu El Izz diabetes 
center. 
The most common indication of major LEA is control of sepsis followed 
by gangrene of the foot and various combinations of sepsis, gangrene and 
extensive tissue loss. 
 Postoperative stump infection rate is (15.71%) with significantly 
higher rates of postoperative stump infection in transfemoral amputations. 
The overall primary healing rate is (76.9%); with significantly lower rates 
for transfemoral amputation.  
 The rate of reoperation is (27.14%). The most common type of 
reoperation is debridement. Requirement of reoperation is significantly 
higher in transfemoral amputation. 
 The in-hospital mortality in our patients is (20%), with significantly 
higher mortality rates in transfemoral amputation. 
There is considerable morbidity due to long hospital stay and the mean 
hospital stay is 30,14days ± SD21.87. 
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4.3 RECOMMENDATION 
 
 There is a need for setting up multidisciplinary foot -care team. Here 
a step by step approach, introducing different elements of the team one by 
one should be considered to create the full team at the outset. 
 Education should be an integral part of foot-care program. Education 
needs to be directed to professionals as well as patients. 
 Patients who have undergone a major amputation should join a 
surveillance program of the other foot. 
 Patient selected for transfemoral amputations are more fragile 
should be assessed carefully for concomitant co morbidity. 
          Vascular status in diabetic patients should be examined to pick up 
cases that can benefit from revascularization and arterial reconstruction 
before major amputation.  
 There is a need to implement and institute certain principles and 
guidelines to reduce the rate of postoperative stump infection. The use of 
broad-spectrum intravenous antibiotics, early postoperative wound 
inspection, performance of open amputations when indicated can be 
considered in this context. 
Surgeons performing amputations should be more aware about the basic 
prosthetic principles and should be more involved in amputee 
rehabilitation. 
  There is a need for accurate registration of amputations. 
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Appendix 
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University of Khartoum 
Faculty of Medicine 
Postgraduate Medical Studies Board 
Clinical MD Surgery  
Major Lower Extremity Amputation in Diabetics 
Clinical patterns 
Serial No. : ……………………… 
(1) Personal Data:  
1. Name: ……………………………… 
2. Age : ……………………………….. 
3. Sex: ………………………………… 
4. Origin: ……………………………… 
5. Occupation: ………………………… 
6. Address & Telephone: ……………… 
(2)  Hospital: ………………………………. 
(3)  Unit…………………………………….. 
(4)  Date of admission……………………… 
(5)  Date of Discharge: ……………………. 
(6)  History: ………. ………… 
(i) Type of DM  
IDDM : …………………. NIDDM: ………………. 
(ii) Duration of DM …………………………………………. 
(iii) Treatment of DM ………………………………………… 
- Diet ………………………………………………….. 
- Insulin ………………………………………………. 
- Oral hypoglycaemi …………………………………... 
(iv) Patient compliance    Yes   No  
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(v) History of hypertension   Yes    No  
(vi) History of smoking   Yes    No  
If yes:  
1. Duration of smoking: ……………………………………… 
2. Number f cigarettes or packs/ day : ………………………… 
3. If stopped time since abstinence: …………………………… 
(vii) History of previous foot education         Yes     No  
(viii) History of previous ulceration     Yes   No  
(ix) History of previous amputation    Yes   No  
If yes :  
1. No of previous amputation ………………………. 
2. Level of previous amputation …………………… 
3. I psi lateral or contra lateral …………………….. 
(7)  Amputation:  
1. Date  
2. Operator 
• Consultant.  
• Registrar.  
• Medical officer 
• House officer  
3. Anesthesia:  
• General: ……………………………………………… 
• Spinal : ……………………………………………… 
• Local: ………………………………………………. 
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4. Amputation level & dexterity:  
 Dexterity 
 Rt  Lt  
1) Transtibial  ……………….. ……..……….. 
2) Transfemoral  ……………….. ……..……….. 
3) Through knee  ……………….. ……..……….. 
4) Hip disarticulation  ……………….. ……..……….. 
5) Others  ……………….. Specify …….. 
(8) Preoperative investigation:  
a. Hb…………………………………………………………. 
b. Blood glucose:   RBG    Fasting  
2 hour postprandial  
c.  Blood urea.    
d. Serum creatinine …………… 
(9) Microbiological studies done:  
                      Yes                  No  
a. What was specimen  
1. Needle aspirate  
2. Wound swab…  
3. Tissue biopsy  
b. What was the, result of C & S  
Organism ……………………………………………….. 
Sensitivity …………………………………………….. 
(10) Radiological studies before surgery:  
  Yes     No  
If yes:  
 Normal    Abnormal  
4 
 
If abnormal what was the abnormality?  
1. Cortical erosion 
2. Radiolucent areas 
3. Periosteal reaction & new bone formation  
4. Soft tissue gas  
5. Sequestration  
6. Neuropathic arthropathy  
7. Others ……………………….  
(11) What was the indication for LL amputation?  
i. Extensive tissue loss  
ii.  Ischemia that cannot be revascularized  
iii. Control of sepsis 
iv. Others…………………………………… 
(12) Wound management after amputation 
 Closed primarily 
Left open  
(13) Use of drains  
 Yes     No  
(14) Postoperative complications  
1. Bleeding 
2. Wound infection 
3. Ischemic stump  
4. Ring Sequestrum  
5. Septicemia  
6. DVT  
7. Others ……………..             Specify …… 
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(15) Healing of the wound after amputation  
a. Occurred primary  
b. Occurred after refashioning  
c. Occurred after another major amputation  
d. Patient died before healing  
e. Did not occur by the end of the observation period  
(16) In Cases of postoperative wound infection what was the result of               
culture & sensitivity?  
Organism ……………………………………………………….. 
Sensitive to …………………………………………………….. 
(17) Requirement of reoperation during that same admission  
 Yes     No  
 If yes  what was the indication  
1. Exploration  
2. Debridement  
3. Refashioning  
4. Major amputation at a more proximal level  
5. Others …………………………….. 
(18) Did the patient develop ulceration on the contralateral limb during 
that same admission?  
 Yes    No  
(19) If yes what type of treatment did it require?  
Debridement  
Drainage  
Dressing  
Amputation  
Others ………………………………………… 
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(20) Duration of hospital stay………………………………….…………… 
(21) If death occurred what were the circumstances of death (possible causes)?  
i. Intraoperative death 
ii. Septicemia & multi organ failure   
iii.  Pulmonary embolism   
iv. Myocardial infraction 
v.  Stroke    
vi.  Others     
 
